drugset / Trial / NCT04333589

Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive

NCT04333589

Unknown 210 enrolled Peking University First Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the mechanism, clinical outcome and therapeutic efficacy with favipiravir of Corona Virus Disease 2019 patients whose nucleic acids changed from negative to positive.

Timeline

Start
2020-04-01
Primary completion
2020-06-01
Completion
2020-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Favipiravir Small molecule 600 mg Oral

Indications